期刊文献+

38例拉米夫定停药后肝炎临床分析 被引量:2

Clinical Characteristics and Retherapyof Lamivudine Withdrawal Hepatitis
下载PDF
导出
摘要 目的研究拉米夫定停药后肝炎的临床特点与再次治疗。方法随访调查拉米夫定停药后复发的慢性乙型肝炎患者,记录用药前病程、诊断,拉米夫定用量、疗程、疗效、停药原因,观察肝功能、血清学及病毒学变化,再次治疗及预后情况。结果38例纳入临床分析。所有病人停药时肝功能正常、HBVDNA降至检测水平以下。14例自行停药,7例有院外购药史,17例遵医嘱停药;肝炎复发距停药的时间4~6个月。肝炎复发后均给以保肝、降酶综合治疗;27例再次服用拉米夫定治疗;5例改用α-干扰素治疗。自行停药者复发后病情较重,其中发生肝功能失代偿3例,肝功衰竭死亡1例。再次应用拉米夫定治疗短期疗效与初次治疗相似。结论慢性乙型肝炎应用拉米夫定治疗停药后易复发,治疗前肝功损害严重者,复发后易出现肝功能失代偿;复发后应尽早应用拉米夫定或其他核苷类药物治疗,同时应加强综合治疗。 Objective: To study the clinical characteristics and the retherapy of lamivudine withdrawal hepatitis. Methods: Patients with recurrent chronic hepatitis B after withdrawing lamivudine were followed up. The course of disease and diagnoses, the dosage of lamivudine, the course of treatment, the curative effective and causes of withdrawing drugs were recorded. The liver function, the changes of serumology and virusology, the retherapy and the prognosis were observed. Results: 38 cases were included in clinical analyses. All the patients had normal liver function when withdrawing drugs and HBVDNA dropped below baseline. 14 cases withdrew drugs by themselves, 7 cases bought drugs out of the hospital and 17 cases withdrew drugs according to the doctors' advice. There were 4 to 6 months between withdrawal drugs and recurrence of hepatitis. General treatment of liver protection and enzyme reduction were given after recurrence. 27 cases took lamivudine again, 5 cases changed to et - interferon. The condition of the patients who withdrew drugs by themselves became relatively serious ; 3 of them had decompensation and 1 of them died of hepatic failure. The short - term curative effect after using lamivudine again and the effect of initial treatment were similar. Conclusion: It is easy for patients with chronic hepatitis B to recur after withdrawing lamivudine. Those whose liver function was seriously damaged before treatment tend to have liver function decompensation after recurrence. Lamivudine should be taken soon after recurrence and combined treatment should be strengthened at the same time.
出处 《泰山医学院学报》 CAS 2006年第8期719-721,共3页 Journal of Taishan Medical College
关键词 慢性乙型肝炎 拉米夫定 停药后肝炎 chronic hepatitis B lamivudine withdrawal hepatitis
  • 相关文献

参考文献7

二级参考文献23

  • 1郭亚兵 喻新民 等.拉米夫定停药后慢性乙型肝炎病情加重3例报道[J].中华肝脏病杂志,2000,8(6):360-360.
  • 2Lok ASF, McMahon BJ. Chronic Hepatitis B. Hepatology, 2001, 34:1225-1241.
  • 3Leung NWY, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology,2001,33 : 1527-1532.
  • 4Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology, 2003, 124 :105-117.
  • 5van Nunen AB, Hansen BE, Suh DJ, et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B:relatlon to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut, 2003,52:420-424.
  • 6Dienstag JL, Cianciara J, Karayalcin S, et al. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology,2003,37 : 748-755.
  • 7Hoofnagle JH. Challenges in therapy of chronic Hepatitis B. EASL International Consensus Conference on Hepatitis B. 13-14 Sep. 2002,Geneva, Switzerland.
  • 8Song BC, Suh DJ, Lee HC, et al. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea. Hepatology, 2000, 32 : 803-806.
  • 9Leung NWY, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology,2001,33:1527-1532.
  • 10van Nunen AB, Hansen BE, Suh DJ, et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut, 2003,52:420-424.

共引文献14128

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部